Provident Clinical Research
15
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
33%
5 trials in Phase 3/4
36%
5 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin
Role: lead
Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia
Role: lead
Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
Role: lead
Clinical Trial to Assess the Effects of Dairy on Insulin Sensitivity and β-Cell Function
Role: lead
Effects of Breakfast on Cognitive Processes in Children
Role: collaborator
Effects of Stearidonic Acid-Containing Foods on Eicosapentaenoic Acid Levels in Red Blood Cells and Omega-3 Index
Role: collaborator
Pilot Study to Assess Adherence to a Novel Eating System in Men and Women With Type 2 Diabetes Mellitus
Role: collaborator
Time and Dose Evaluation of Stearidonic Acid (SDA) to Eicosapentaenoic Acid (EPA) in Red Blood Cells
Role: collaborator
Clinical Trial to Assess the Effects of Low-fat Dairy on Systolic Blood Pressure
Role: collaborator
A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study
Role: collaborator
Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale
Role: collaborator
Study to Determine the Digestive and Physiological Effects of an Extract From Bran in Healthy Men and Women
Role: collaborator
Clinical Study to Test the Effects of a Low-Carbohydrate Diet on Body Weight
Role: lead
Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss
Role: lead
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
Role: lead
All 15 trials loaded